Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

ARCHIVES : 309 forms

Sorting of results :

PREFACE - Study on the prevalence of facial lipoatrophy in patients infected by HIV virus receiving antiretroviral drugs - FRAN08-005

Head : Cohen-Codar Isabelle

Version 3
Voir
View
Overview

91

Last update : 07/01/2019

ARCHIVE

PREFACE - Study on the prevalence of facial lipoatrophy in patients infected by HIV virus receiving antiretroviral drugs - FRAN08-005

Head : Cohen-Codar Isabelle

Main objective

Describe the prevalence of the facial lipoatrophy in patients infected by HIV virus and receiving antiretroviral drugs. Describe the prevalence of lipoatrophies and lipodystrophic mixed syndromes.
Evaluate the score of quality of life, using the patients multi-dimensional auto-questionnaire and specific ABCD "Assessment of Body Change and Distress".

Inclusion criteria

Patient infected by HIV virus, receiving antiretroviral drugs for at least 1 month and coming to consultation at his usual follow-up center, during the period of the study, obtaining of the written consent for the collect and exploitation of his personal data.

Last update : 07/01/2019

Voir
View

B009 - Follow-up study of patients treated with drotrecogin alfa (activated) (Xigris®) in France

Head : Laboratoire , Eli Lilly France

Version 1
Voir
View
Overview

92

Last update : 01/01/2019

ARCHIVE

B009 - Follow-up study of patients treated with drotrecogin alfa (activated) (Xigris®) in France

Head : Laboratoire , Eli Lilly France

Main objective

Primary objective: evaluate 1-month mortality (at 28 days and 31 days) of patients treated with drotrecogin alpha (activated) in intensive care forsevere sepsis and describe causes of death.
Secondary objectives: characteristics of patients and conditions of use.

Inclusion criteria

All adult patients treated with drotrecogin alpha (activated) in France in the course of routine care in intensive care services.

Last update : 01/01/2019

Voir
View

Flurec - Recurring influenza virus infections and implications in terms of epidemic recurrences and pandemic risk.

Head : Carrat Fabrice, UMR-S 707 / Epidémiologie des maladies infectieuses et modélisation
De Lamballerie Xavier, UMR-D 190, Emergence des pathologies virales

Version 1
Voir
View
Overview

93

Last update : 01/01/2020

ARCHIVE

Flurec - Recurring influenza virus infections and implications in terms of epidemic recurrences and pandemic risk.

Head : Carrat Fabrice, UMR-S 707 / Epidémiologie des maladies infectieuses et modélisation
De Lamballerie Xavier, UMR-D 190, Emergence des pathologies virales

Main objective

To explore cross-protective immunity involving different A/H1N1 viruses (seasonal and pandemic) and the seasonal A/H3N2 virus through data gathered from this study. This study also aims to identify the epidemiological, immunological and virological factors that determine the risk of recurring influenza infections as well as characterise the population's herd immunity and its evolution.

Inclusion criteria

The "influenza" group comprises of patients enrolled after general medical consultation for influenza-like illness during seasonal epidemic. The "non-influenza" group comprises of patients enrolled after general medical consultation during seasonal epidemic for a reason other than influenza, yet that was acute in nature e.g. infectious diarrhoea, minor trauma.

Last update : 01/01/2020

Voir
View

CEPHEUS - Assessment of lipid-lowering treatment in France

Head : Ferrières Jean, Département d'épidémiologie INSERM UMR1027

Version 3
Voir
View
Overview

94

Last update : 09/05/2017

ARCHIVE

CEPHEUS - Assessment of lipid-lowering treatment in France

Head : Ferrières Jean, Département d'épidémiologie INSERM UMR1027

Main objective

Determine the proportion of patients on lipid-lowering drugs who reach the LDL-C goals recommended in guidelines.

Inclusion criteria

man or woman - adult - treated with lipid-lowering drugs for at least three months, with no dose adjustment for a minimum of six weeks

Last update : 09/05/2017

Voir
View

ABSINTHE - Observational study of the therapeutic strategy in the management of acute sinusitis in primary care

Head : Moore Nicholas, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen

Version 2
Voir
View
Overview

95

Last update : 09/05/2017

ARCHIVE

ABSINTHE - Observational study of the therapeutic strategy in the management of acute sinusitis in primary care

Head : Moore Nicholas, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen

Main objective

The study objectives were to describe the management of acute sinusitis in real-life conditions of prescription and to evaluate the effectiveness of the initial therapeutic strategy.

Inclusion criteria

Patient consulting for acute sinusitis diagnosed according to criteria of the practitioner; Patient without a previous episode of acute sinusitis during the two months preceding diagnosis; Patient aged 18 years and over; Patient agreeing to participate in the study; Patient not included in a clinical trial (Huriet-Sérusclat); Patient who may be followed for two months; Patient showing no severe active disease (life-threatening in the next three months).

Last update : 09/05/2017

Voir
View

- Health barometer

Head : BECK François

Version 1
Voir
View
Overview

96

Last update : 01/01/2020

ARCHIVE

- Health barometer

Head : BECK François

Main objective

Follow the evolution of some basic indicators about behavior and attitudes towards health on general population. Follow the evolution by age group, gender, sub-populations… according to the large size of the sample. Feed the different INPES information programs concerning behaviors, opinion and attitudes towards health as well as determinants (associates factors) of these opinions.
Study, thanks to the large size of the sample, sub-populations specificities (young people, old people, students, unemployed people) and unusual behaviors.
Study the links between representations and behaviors concerning health

(the difference between barometers and other health surveys is that they are surveys about prevention practices and lifestyles concerning health factors. There is no attempt to measure exactly health conditions. A relevant part of the questionnaire concerns sensitive topics such as addictions, mental health, sexual behaviors, etc.)

Being complementary to other big health surveys (avoid repetition, research coherence), in a collaborative effort.
Participate, thanks to the large size of the base, to the production of regional data, in collaboration with the ORS.
In the dimension study/observation, it will also be a point of support for the evaluation of public politics: indicators of the follow of Public Health laws, assessment of government plans (addictions plan, mental health plan, ageing well…)

Inclusion criteria

Question people belonging to households:
- Equipped with a fixed telephone line (white, orange or red list)
- Equipped with just a mobile phone
- Full unbundled access

Last update : 01/01/2020

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here